LAPTOP (NEAT44) – The Late Presenter Treatment Optimisation Study  

​

An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients with Advanced HIV-Disease 

​

Status:  Ongoing, (closed to recruitment) 

 

SPONSOR: NEAT ID Foundation 

 

Sponsor code: NEAT44 

EudraCT: 2018-003481-13 

 

Phase:  III

 

Indication:  ART-naïve HIV-1 infected patients

​

Sites: 55

​

Territories : 7

​

​

​